Figure 4.
Overall survival and freedom from local progression at 2 years for 11 patients accrued to a phase II clinical trial for unresectable pancreatic cancer. Image borrowed from Ref. [19].
Overall survival and freedom from local progression at 2 years for 11 patients accrued to a phase II clinical trial for unresectable pancreatic cancer. Image borrowed from Ref. [19].